MannKind Corp.
(NASDAQ : MNKD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 4.33%154.810.0%$1863.66m
NVAXNovavax, Inc. 4.39%231.2392.9%$1423.06m
OCGNOcugen, Inc. 36.88%10.950.0%$1213.37m
AMGNAmgen, Inc. -1.14%224.921.3%$594.80m
ILMNIllumina, Inc. -1.45%439.413.5%$530.13m
REGNRegeneron Pharmaceuticals, Inc. -0.58%450.572.7%$522.91m
VRTXVertex Pharmaceuticals, Inc. -0.20%212.551.9%$515.41m
GILDGilead Sciences, Inc. -2.21%61.401.0%$485.52m
BIIBBiogen, Inc. -1.58%272.881.7%$380.18m
BNGOBioNano Genomics, Inc. -2.89%9.730.0%$374.38m
ALXNAlexion Pharmaceuticals, Inc. -0.59%152.752.0%$371.25m
CRSPCRISPR Therapeutics AG -1.25%125.690.6%$292.02m
EXASEXACT Sciences Corp. 3.67%136.1218.4%$252.07m
SGENSeagen Inc. 0.68%151.115.8%$212.33m
VXRTVaxart, Inc. -4.67%7.150.0%$210.57m

Company Profile

MannKind Corp. is a biopharmaceutical company. It focuses on the discovery, development and, commercialization of therapeutic products for diseases, such as diabetes and cancer. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Westlake Village, CA.